Molecular Diagnosis of Cystic Fibrosis: Comparison of Four Analytical Procedures
Authors:
- Rossella TomaiuoloRossella Tomaiuolo
- Mariacristina SpinaMSMariacristina Spina
- Giuseppe CastaldoGCGiuseppe Castaldo
- 27 January 2003
- journal article
- research article
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 41 (1) , 26-32
Abstract
We compared the analytical accuracy, times, costs and the detection rate of four procedures for the molecular analysis of cystic fibrosis (CF). DNA from 127 subjects bearing different genotypes was tested by denaturating gradient gel electrophoresis followed by sequencing (reference procedure) and, for comparison, by ASO dot-blot (in-house), reverse dot-blot (Innogenetics), ARMS (Zeneca Diagnostics) and OLA-PCR (PE Applied Biosystem). To assess inter-observer variability, all samples were tested twice. To evaluate intra- and between-series variability, two samples were tested twice in each series. All the procedures yielded reproducible results and assigned the correct genotype to each sample. ASO dot-blot is the cheapest procedure but has the longest analytical time (> 24 h) and uses radioactive labeling. It can be adapted to analyze peculiar mutations in specific ethnic groups. ARMS from Zeneca Diagnostics is rapid (4 h), easy to perform, but, except for the AF508 mutation, does not distinguish the homozygote from the heterozygote genotype. It could be used for carrier analysis in families with known mutations. OLA-PCR has the highest detection rate in most ethnic groups, is automated for capillary electrophoresis but requires a high level of operator expertise: it is suitable when collected series of samples are analyzed from large patient cohorts. Reverse dot-blot is easy to perform and can be semiautomated: it can be used as first-line screening test. Given the heterogeneity of CF mutations, commercial kits should be developed to analyze mutations peculiar to specific ethnic groups.Keywords
This publication has 21 references indexed in Scilit:
- Genetic testing and quality control in diagnostic laboratoriesNature Genetics, 2000
- Screening practices for mutations in the CFTR gene ABCC7Human Mutation, 2000
- A Practical Guide for the Validation of Genetic TestsGenetic Testing, 1999
- Diversity of Cystic Fibrosis Mutation-Screening PracticesThe American Journal of Human Genetics, 1998
- Evaluation of CFTR gene mutation testing methods in 136 diagnostic laboratories: report of a large European external quality assessmentEuropean Journal of Human Genetics, 1998
- Genetic history of cystic fibrosis mutations in Italy. I. Regional distributionAnnals of Human Genetics, 1997
- Molecular epidemiology of cystic fibrosis mutations and haplotypes in southern Italy evaluated with an improved semiautomated robotic procedure.Journal of Medical Genetics, 1996
- A rapid, efficient, and sensitive assay for simultaneous detection of multiple cystic fibrosis mutationsHuman Mutation, 1993
- A termination mutation (2143delT) in the CFTR gene of German cystic fibrosis patientsHuman Genetics, 1992
- Molecular characterization of cystic fibrosis: 16 Novel mutations identified by analysis of the whole cystic fibrosis conductance transmembrane regulator (CFTR) coding regions and splice site junctionsGenomics, 1992